Real-time ultrasound (RTU) imaging methods for quality control of meats

In this chapter the use of real-time ultrasonography to predict in vivo carcass composition and meat traits will be reviewed. The chapter begins by discussing background and principles of ultrasound. Then aspects affecting the suitability of realtime ultrasonography and image analysis for predicting carcass composition and meat traits of meat producing species and fish will be presented. This chapter also provides an overview of the present and future trends in the application of real-time ultrasonography in the meat industry. © 2012 Woodhead Publishing Limited All rights reserved.info:eu-repo/semantics/publishedVersio

EPIdemiology of Surgery-Associated Acute Kidney Injury (EPIS-AKI) : Study protocol for a multicentre, observational trial

More than 300 million surgical procedures are performed each year. Acute kidney injury (AKI) is a common complication after major surgery and is associated with adverse short-term and long-term outcomes. However, there is a large variation in the incidence of reported AKI rates. The establishment of an accurate epidemiology of surgery-associated AKI is important for healthcare policy, quality initiatives, clinical trials, as well as for improving guidelines. The objective of the Epidemiology of Surgery-associated Acute Kidney Injury (EPIS-AKI) trial is to prospectively evaluate the epidemiology of AKI after major surgery using the latest Kidney Disease: Improving Global Outcomes (KDIGO) consensus definition of AKI. EPIS-AKI is an international prospective, observational, multicentre cohort study including 10 000 patients undergoing major surgery who are subsequently admitted to the ICU or a similar high dependency unit. The primary endpoint is the incidence of AKI within 72 hours after surgery according to the KDIGO criteria. Secondary endpoints include use of renal replacement therapy (RRT), mortality during ICU and hospital stay, length of ICU and hospital stay and major adverse kidney events (combined endpoint consisting of persistent renal dysfunction, RRT and mortality) at day 90. Further, we will evaluate preoperative and intraoperative risk factors affecting the incidence of postoperative AKI. In an add-on analysis, we will assess urinary biomarkers for early detection of AKI. EPIS-AKI has been approved by the leading Ethics Committee of the Medical Council North Rhine-Westphalia, of the Westphalian Wilhelms-University Münster and the corresponding Ethics Committee at each participating site. Results will be disseminated widely and published in peer-reviewed journals, presented at conferences and used to design further AKI-related trials. Trial registration number NCT04165369

Le don d’organes en France

International audienc

Les compléments alimentaires, des produits frontières ?

International audienc

L’accès dématérialisé aux tests génétiques : l’illusoire autonomie du patient ?

International audienc

Promouvoir la sécurité sanitaire des tests génétiques dans le cadre du e-commerce : tirer les leçons du médicament

International audienc

La vente en ligne des tests génétiques, une offre prématurée ?

International audienc

The dematerialization of access to genetic tests and the rights and obligations of partners in the care relationship

La dématérialisation de l’accès aux tests génétiques apparaît comme un outil concourant à satisfaire l’ensemble des composantes du droit à la protection de la santé. En effet, en la matière, la spécialisation de la médecine induit une limitation des personnes habilitées à prescrire des tests génétiques. Aussi, la recherche de la meilleure sécurité sanitaire possible pour la réalisation des tests génétiques induit des problématiques d’égal accès aux laboratoires de biologie médicale autorisés à cet effet, mais auxquelles la dématérialisation peut apporter des réponses. Aussi, elle n’apparaît pas être antinomique de l’autonomie des patients, bien qu’elle présente des faiblesses.The dematerialization of access to genetic testing appears to be a tool to satisfy all the aspects of the right to health protection. Indeed, in this field, the specialization of medicine induces a limitation of the numbers of persons entitled to prescribe genetic tests. The quest for the best quality and health security for the realization of the genetic tests induces problems of equal access to the laboratories of medical biology authorized for this purpose, but to which dematerialization can give answers. Also, dematerialization does not appear to be antinomic of patient autonomy, although it presents weaknesses

Les compléments alimentaires au prisme du droit

International audienc

Examens de biologie médicale destinés à établir un diagnostic prénatal : du nouveau

International audienc